The Patent Finder

17-Hydroxyprogesterone Ester-Containing Oral Compositions and Related Methods

Lipocine Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 6 of these applications claim priority to application 13/193,571, filed Jul 28, 2011. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 8,951,99617-Hydroxyprogesterone Ester-Containing Oral Compositions and Related Methods
In force
 · High confidence
Lipocine Inc.In force
High confidence
US 9,358,29817-Hydroxyprogesterone Ester Containing Oral Compositions and Related Methods
In force
 · High confidence
Lipocine Inc.In force
High confidence
US 9,358,29917-Hydroxyprogesterone Ester-Containing Oral Compositions and Related Methods
In force
 · High confidence
Lipocine Inc.In force
High confidence
US 9,364,54717-Hydroxyprogesterone Ester Containing Oral Compositions and Related Methods
In force
 · High confidence
Lipocine Inc.In force
High confidence
US 9,399,06917-Hydroxyprogesterone Ester Containing Oral Compositions and Related Methods
In force
 · High confidence
Lipocine Inc.In force
High confidence
US 10,022,38417-Hydroxyprogesterone Ester-Containing Oral Compositions and Related Methods
In force
 · Medium confidence
Lipocine Inc.In force
Medium confidence
US 11,471,47017-Hydroxyprogesterone Ester-Containing Oral Compositions and Related Methods
In force
 · Medium confidence
Lipocine Inc.In force
Medium confidence
US 10,709,71617-Hydroxyprogesterone Ester-Containing Oral Compositions and Related Methods
Lapsed Jul 14, 2024 on the fee record
Medium confidence
Lipocine Inc.Lapsed Jul 14, 2024 on the fee record
Medium confidence
Application 15/266,20617-Hydroxyprogesterone Ester-Containing Oral Compositions and Related Methods
Abandoned
Abandoned Sep 17, 2018
Lipocine Inc.AbandonedAbandoned Sep 17, 2018
Application 16/010,18817-Hydroxyprogesterone Ester-Containing Oral Compositions and Related Methods
Abandoned
Abandoned Apr 2, 2019
Lipocine Inc.AbandonedAbandoned Apr 2, 2019
10 of 10 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
7 of these are in force and held by Lipocine Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited